Regeneron Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 27,833 | 0.2% | 36,038 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 21,150 | 0.2% | 37,625 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 19,772 | 0.2% | 37,676 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 24,220 | 0.2% | 38,168 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 26,798 | 0.3% | 37,519 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 39,619 | 0.4% | 37,698 | 9/30/2024 |
| 2024 Q2 | 8/6/2024 | 43,705 | 0.6% | 41,598 | 6/30/2024 |
| 2024 Q1 | 5/13/2024 | 39,095 | 0.5% | 40,648 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 35,238 | 0.5% | 40,120 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 33,373 | 0.4% | 40,679 | 9/30/2023 |
| 2023 Q2 | 8/4/2023 | 29,788 | 0.4% | 41,485 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 32,874 | 0.4% | 40,013 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 29,302 | 0.4% | 40,557 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 27,234 | 0.4% | 39,584 | 9/30/2022 |
| 2022 Q2 | 8/8/2022 | 25,745 | 0.4% | 43,549 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 22,832 | 0.3% | 32,471 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 18,869 | 0.3% | 29,546 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 6,096 | 0.1% | 10,049 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 3,747 | 0.1% | 7,019 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 1,331 | 0.0% | 2,813 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 2,307 | 0.1% | 4,776 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 2,368 | 0.1% | 4,232 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 2,391 | 0.1% | 3,834 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 465 | 0.0% | 953 | 3/31/2020 |
| 2019 Q4 | 2/13/2020 | 328 | 0.0% | 875 | 12/31/2019 |